Skip to product information
1 of 3

Zoetis

Bovi-Shield GOLD FP 5 L5

Bovi-Shield GOLD FP 5 L5

Regular price $13.59 USD
Regular price Sale price $13.59 USD
Sale Sold out
Shipping calculated at checkout.
NOTIFY ME WHEN IN STOCK
Size
Modified-live virus and bacterin combination for vaccination of healthy cows and heifers prior to breeding to prevent persistently infected calves caused by BVD Types 1 & 2; and as an aid in preventing abortion caused by IBR; respiratory disease caused by IBR, BVD Types 1 & 2, PI3, BRSV; BVD Type 2 testicular infection; and disease caused by the 5 most common strains of Lepto, including L. hardjo.

Please see shipping information regarding vaccines before placing order. 
Aids in prevention of BVD Types 1 & 2 Fetal Infection. Bovi Shield GOLD FP 5 L5 HB prevents establishment of L. hardjo in the kidney for at least 12 months; aids in preventing infection of the fetus; and has 12-month DOI against IBR-induced abortion and persistently infected calves caused by BVD Types 1 & 2.

May safely be administered to pregnant cattle provided they were vaccinated, according to label directions (prior to breeding initially), with any Bovi-Shield FP or PregGuard FP vaccine within the past 12 months. May also be administered to calves nursing pregnant cows provided their dams were vaccinated within the past 12 months as described above.

Dosage: 2 ml IM or subcut to all breeding cows and heifers about 1 month prior to breeding or being added to herd. Revaccinate with Spirovac L5 in 4-6 weeks. Revaccinate annually.

Do not use in pregnant cows or calves nursing pregnant cows, unless they were previously vaccinated according to label instructions. 21 day slaughter withdrawal.

Zoetis stands behind their Bovi-Shield Gold FP 5 vaccines with the Fetal Protection (FP) Support Guarantee. The FP Support Guarantee is their commitment to providing veterinarians and producers with confidence that their decision to use Zoetis-branded reproductive vaccines will be supported if a calf is identified with Bovine Viral Diarrhea Virus (BVDV) persistent infection (PI), or if there is an abortion due to Infectious Bovine Rhinotracheitis Virus (IBR).

Manufacturer and/or Label Information

ZOETIS INC.
333 PORTAGE STREET, KALAMAZOO, MI, 49007
Telephone: 269-359-4414
Customer Service: 888-963-8471
Website: www.zoetis.com
THIS SERVICE AND DATA ARE PROVIDED "AS IS". DVMetrics assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics service and data. See the Terms of Use for further details.
Bovi-Shield GOLD® FP® 5 L5

Zoetis

Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza3-Respiratory Syncytial Virus Vaccine

Modified Live Virus

Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin

INDICATIONS: Bovi-Shield GOLD FP 5 L5 is for vaccination of healthy cows and heifers prior to breeding to prevent persistently infected calves caused by bovine virus diarrhea (BVD) virus Types 1 and 2 and as an aid in preventing abortion caused by infectious bovine rhinotracheitis (IBR, bovine herpesvirus Type 1) virus; respiratory disease caused by IBR, BVD Types 1 and 2, parainfluenza3 (PI3) and bovine respiratory syncytial virus (BRSV); BVD Type 2 testicular infection; and leptospirosis caused by Leptospira canicola, L. grippotyphosa, L. hardjo, L. icterohaemorrhagiae, and L. pomona. A 12-month duration of immunity has been demonstrated against IBR-induced abortion and persistently infected calves caused by BVD Types 1 and 2. Bovi-Shield GOLD FP 5 L5 may be administered to pregnant cattle provided they were vaccinated, according to label directions, with any Bovi-Shield GOLD FP or PregGuard® GOLD FP vaccine within the past 12 months. Bovi-Shield GOLD FP 5 L5 may also be administered to calves nursing pregnant cows provided their dams were vaccinated within the past 12 months as described above. To help ensure safety in pregnant cattle, heifers must receive at least 2 doses of any Bovi-Shield GOLD FP or PregGuard GOLD FP product with the second dose administered approximately 30 days prebreeding.

PRODUCT DESCRIPTION: Bovi-Shield GOLD FP 5 L5 is a freeze-dried preparation of modified live virus (MLV) strains of IBR, BVD (Types 1 and 2), PI3, and BRSV viruses, plus a liquid bacterin containing the 5 Leptospira serovars identified above. The liquid bacterin is used to rehydrate the freeze-dried vaccine.

DIRECTIONS:

General Directions: Vaccination of healthy cattle is recommended. Aseptically rehydrate the freeze-dried vaccine (Bovi-Shield GOLD FP 5) with the liquid bacterin provided (Leptoferm-5®+A), shake well, and administer 2 mL intramuscularly. In accordance with Beef Quality Assurance guidelines, this product should be administered in the muscular region of the neck.

Primary Vaccination: Administer a single 2-mL dose to all breeding cows and heifers approximately 1 month prior to breeding or being added to the herd.

Revaccination: Annual revaccination with a single dose of Bovi-Shield GOLD FP 5 L5 is recommended.

Good animal husbandry and herd health management practices should be employed.

PRECAUTIONS:

Do not use in pregnant cows (abortions can result) unless they were vaccinated, according to label directions, with any Bovi-Shield GOLD FP or PregGuard GOLD FP vaccine within the past 12 months. Do not use in calves nursing pregnant cows unless their dams were vaccinated within the past 12 months as described above.

To help ensure safety in pregnant cattle, heifers must receive at least 2 doses of any Bovi-Shield GOLD FP or PregGuard GOLD FP product with the second dose administered approximately 30 days prebreeding.

Store at 2°-7°C. Prolonged exposure to higher temperatures and/or direct sunlight may adversely affect potency. Do not freeze.

Use entire contents when first opened.

Sterilized syringes and needles should be used to administer this vaccine.

Do not sterilize with chemicals because traces of disinfectant may inactivate the vaccine.

Burn containers and all unused contents.

Do not vaccinate within 21 days before slaughter.

Contains gentamicin as preservative.

As with many vaccines, anaphylaxis may occur after use. Initial antidote of epinephrine is recommended and should be followed with appropriate supportive therapy.

This product has been shown to be efficacious in healthy animals. A protective immune response may not be elicited if animals are incubating an infectious disease, are malnourished or parasitized, are stressed due to shipment or environmental conditions, are otherwise immunocompromised, or the vaccine is not administered in accordance with label directions.

Technical inquiries should be directed to Zoetis Inc. Veterinary Services, (888) 963-8471 (USA), (800) 461-0917 (Canada).

For veterinary use only.

U.S. Veterinary License No. 190

Zoetis Inc., Kalamazoo, MI 49007, USA

13952200

Presentation: 5, 10, and 50 dose vials.

CPN: 3690207.9



Dimensions

Care information

View full details